2024 Japan Hospital Infectious Disease Market: Supplier Shares by Test, Volume and Sales Segment Forecasts for 100 Tests, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
This new report from LeadingMarketResearch.com contains 887 pages and 72 tables.The report is available by section, and can be customized to specific information needs and budget.The report presents a comprehensive analysis of the Italian hospital infectious disease testing market, including: Major issues pertaining to the Italian hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.;Current scientific views on definition, epidemiology, and etiology of major infectious diseases and microorganisms.;Volume and sales forecasts for 80 infectious disease tests performed in Italian hospital laboratories.;Instrumentation technologies and feature comparison of leading analyzers.;Sales and market shares of leading suppliers.; Emerging diagnostic technologies and their potential market applications.; Product development opportunities.; Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.; Business opportunities and strategic recommendations for suppliers.Contains 887 pages and 72 tables
Introduction
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. AIDS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. ADENOVIRUS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
3. AEROMONAS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. ANTHRAX/BACILLUS ANTHRACIS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. ARBOVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. BABESIOSIS
a. Background
7. BACILLARY EPITHELIOID ANGIOMATOSIS (BEA) AND OTHER
Bartonella (Rochalimaea)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. BLASTOCYSTIS HOMINIS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. BRUCELLA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
10. CAMPYLOBACTER
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
11. CANDIDA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
12. CHAGAS DISEASE
a. Background
13. CHANCROID
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
14. CHLAMYDIA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
15. CLOSTRIDIUM DIFFICILE
a. Background
b. Diagnostic Tests
c. Drugs and Vaccines
16. CORONAVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
17. COXSACKIEVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
18. CREUTZFELDT-JAKOB’S DISEASE
a. Background
b. Diagnostic Tests
c. Vaccines
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. AIDS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. ADENOVIRUS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
3. AEROMONAS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. ANTHRAX/BACILLUS ANTHRACIS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. ARBOVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. BABESIOSIS
a. Background
7. BACILLARY EPITHELIOID ANGIOMATOSIS (BEA) AND OTHER
Bartonella (Rochalimaea)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. BLASTOCYSTIS HOMINIS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. BRUCELLA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
10. CAMPYLOBACTER
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
11. CANDIDA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
12. CHAGAS DISEASE
a. Background
13. CHANCROID
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
14. CHLAMYDIA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
15. CLOSTRIDIUM DIFFICILE
a. Background
b. Diagnostic Tests
c. Drugs and Vaccines
16. CORONAVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
17. COXSACKIEVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
18. CREUTZFELDT-JAKOB’S DISEASE
a. Background
b. Diagnostic Tests
c. Vaccines
More Publications
2019-2023 Japan Microbiology Automated Market: Supplier Shares and Strategies, Country Segment Forecasts, Technology and Instrumentation Review--Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics
US$ 8,850.00
February 2019
421 pages
2013 Japan Flow Cytometry Market: Opportunities and Strategies for Suppliers
US$ 3,600.00
December 2012
142 pages
2020 Japan Clinical Chemistry and Immunodiagnostic Markets: Sales and Market Shares of Major Reagent and Instrument Suppliers, Strategic Profiles of Leading Competitors
US$ 2,500.00
February 2020
73 pages
2017 Japan Virology and Bacteriology Testing Market: Future Horizons and Growth Strategies--Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities by Test
US$ 7,920.00
March 2017
976 pages
2015-2019 Japanese HIV/AIDS Diagnostic Testing Market: Supplier Shares and Country Forecasts
US$ 1,840.00
June 2015
250 pages
